· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Лечебное дело 2022 / N 3/4 Воспалительный синдром восстановления иммунной системы у лиц, живущих с ВИЧ: поиск биомаркеров для прогнозирования, профилактики и лечения А.Л. Свентицкая, Е.И. Веселова, Г.Д. Каминский Список литературы/References 1. World Health Organization. Fact sheets. Detail. HIV. Accessed 2023 Jan 09. https://www.who.int/news-room/fact-sheets/detail/hiv-aids 2. Dwomoh D, Tambaa C, Ayisi Addo S, Wiah E, Abdulai M, Bosomprah S. Effect of antiretroviral therapy on all-cause mortality among people living with HIV/AIDS in Ghana using Mahalanobis distant metric matching within propensity score caliper analysis: a retrospective cohort study. PLoS One. 2018;13(9):e0203461. DOI: 10.1371/journal.pone.0203461 3. Boatman JA, Baker JV, Emery S, Furrer H, Mushatt DM, Sedláček D, Lundgren JD, Neaton JD. Risk factors for low CD4+ count recovery despite viral suppression among participants initiating antiretroviral treatment with CD4+ counts >500 cells/mm3: findings from the Strategic Timing of AntiRetroviral Therapy (START) trial. Journal of Acquired Immune Deficiency Syndrome. 2019;81(1):10-17. DOI: 10.1097/QAI.0000000000001967 4. TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X. Atrial of early antiretrovirals and isoniazid preventive therapy in Africa. The New England Journal of Medicine. 2015;373(9):808-822. DOI: 10.1056/NEJMoa1507198 5. Министерство здравоохранения РФ; Национальная ассоциация специалистов по профилактике, диагностике и лечению ВИЧ инфекции; Национальная вирусологическая ассоциация. Клинические рекомендации. ВИЧ-инфекция у взрослых. МКБ 10: B20, B21, B22, B23, B24, Z21. Год утверждения (частота пересмотра): 2020. М., 2020. 87 с. [Ministry of Health of the Russian Federation; National Association of Specialists in the Prevention, Diagnosis and Treatment of HIV Infection; National Virological Association. Clinical recommendations. HIV infection in adults. ICD 10: B20, B21, B22, B23, B24, Z21. Year of approval (frequency of revision): 2020. Moscow, 2020. 87 p. (In Russ.).] 6. Sharma SK, Dhooria S, Barwad P, Kadhiravan T, Ranjan S, Miglani S, Gupta D. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case definition. Indian Journal of Medical Research. 2010;131:804-808. PMID: 20571170 7. Sharma SK, Soneja M. HIV & immune reconstitution inflammatory syndrome (IRIS). Indian Journal of Medical Research. 2011;134(6):866-877. DOI: 10.4103/0971-5916.92632 8. Djawe K, Buchacz K, Hsu L, Chen MJ, Selik RM, Rose C, Williams T, Brooks JT, Schwarcz S. Mortality risk after AIDS-defining opportunistic illness among HIV-infected persons – San Francisco, 1981–2012. The Journal of Infectious Diseases. 2015;212(9):1366-1375. DOI: 10.1093/infdis/jiv235 9. Masur H, Read SW. Opportunistic infections and mortality: still room for improvement. The Journal of Infectious Diseases. 2015;212(9):1348-1350. DOI: 10.1093/infdis/jiv236 10. Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d’Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD; Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD. The incidence of AIDS-defining illnesses at a current CD4 count ≥200 cells/μL in the post-combination antiretroviral therapy era. Clinical Infectious Diseases. 2013;57(7):1038-1047. DOI: 10.1093/cid/cit423 11. Kroeze S, Wit FW, Rossouw TM, Steel HC, Kityo CM, Siwale M, Akanmu S, Mandaliya K, de Jager M, Ondoa P, Reiss P, Rinke de Wit TF, Kootstra N, Hamers RL. Plasma biomarkers of human immunodeficiency virus-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy. The Journal of Infectious Diseases. 2019;220(6):1029-1033. DOI: 10.1093/infdis/jiz252 12. Viskovic K, Begovac J. Tuberculosis-associated immune reconstruction inflammatory syndrome (TB-IRIS) in HIV-infected patients: report of two cases and the literature overview. Case Reports in Infectious Diseases. 2013;2013:323208. DOI: 10.1155/2013/323208 13. Bana TM, Lesosky M, Pepper DJ, van der Plas H, Schutz C, Goliath R, Morroni C, Mendelson M, Maartens G, Wilkinson RJ, Meintjes G. Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors. BMC Infectious Diseases. 2016;16(1):518. DOI: 10.1186/s12879-016-1850-2 14. Walker NF, Stack S, Wasserman S, Wilkinson RJ, Meintjes G. The tuberculosis-associated immune reconstitution inflammatory syndrome associated with tuberculosis: recent advances in clinical and pathogenetic research. Current Opinion in HIV and AIDS. 2018;13(6):512-521. DOI: 10.1097/COH.0000000000000502 15. Lage SL, Wong CS, Amaral EP, Sturdevant D, Hsu DC, Rupert A, Wilson EMP, Qasba SS, Naqvi NS, Laidlaw E, Lisco A, Manion M, Sereti I. Classical complement and inflammasome activation converge in CD14highCD16- monocytes in HIV associated TB-immune reconstitution inflammatory syndrome. PLoS Pathogenes. 2021;17(3):e1009435. DOI: 10.1371/journal.ppat.1009435 16. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. Journal of Antimicrobial Chemotherapy. 2006;57(2):167-170. DOI: 10.1093/jac/dki444 17. Nusbaum RJ, Calderon VE, Huante MB, Sutjita P, Vijayakumar S, Lancaster KL, Hunter RL, Actor JK, Cirillo JD, Aronson J, Gelman BB, Lisinicchia JG, Valbuena G, Endsley JJ. Pulmonary tuberculosis in humanized mice infected with HIV-1. Scientific Reports. 2016;6:21522. DOI: 10.1038/srep21522 18. Lai RPJ, Meintjes G, Wilkinson KA Graham CM, Marais S, Van der Plas H, Deffur A, Schutz C, Bloom C, Munagala I, Anguiano E, Goliath R, Maartens G, Banchereau J, Chaussabel D, O’Garra A, Wilkinson RJ. HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling. Nature Communications. 2015;6:8451. DOI: 10.1038/ncomms9451 19. Andrade BB, Singh A, Narendran G, Schechter ME, Nayak K, Subramanian S, Anbalagan S, Jensen SM, Porter BO, Antonelli LR, Wilkinson KA, Wilkinson RJ, Meintjes G, van der Plas H, Follmann D, Barber DL, Swaminathan S, Sher A, Sereti I. Mycobacterial antigen driven activation of CD14++CD16– monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome. PLoS Pathogenes. 2014;10(10):e1004433. DOI: 10.1371/journal.ppat.1004433 20. Sereti I, Rodger AJ, French MA. Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Current Opinion in HIV and AIDS. 2010;5(6):504-510. DOI: 10.1097/COH.0b013e32833ed774 21. Grant PM, Komarow L, Lederman MM, Pahwa S, Zolopa AR, Andersen J, Asmuth DM, Devaraj S, Pollard RB, Richterman A, Kanthikeel S, Sereti I. Elevated interleukin 8 and cytokine Th cells 1 and Th cells 17 levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164. The Journal of Infectious Diseases. 2012;206(11):1715-1723. DOI: 10.1093/infdis /jis604 22. Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, Gicquel B, Vicaut E, Lagrange PH, Sereni D, Autran B. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS (London, England). 2006;20(2):F1-F7. DOI: 10.1097/01.aids.0000202648.18526.bf 23. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, Elliott JH, Murdoch D, Wilkinson RJ, Seyler C, John L, van der Loeff MS, Reiss P, Lynen L, Janoff EN, Gilks C, Colebunders R; International Network for the Study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. The Lancet. Infectious Diseases. 2008;8(8):516-523. DOI: 10.1016/S1473-3099(08)70184-1 24. Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French MA, Price P. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS (London, England). 2011;25(12):1455-1460. DOI: 10.1097/QAD.0b013e328348fb18 25. Marais S, Lai RPJ, Wilkinson KA, Meintjes G, O’Garra A, Wilkinson RJ. Inflammasome activation underlying central nervous system deterioration in HIV-associated tuberculosis. The Journal of the Infectious Diseases. 2017;215(5):677-686. DOI: 10.1093/infdis/jiw561 26. Pean P, Nerrienet E, Madec Y, Borand L, Laureillard D, Fernandez M, Marcy O, Sarin C, Phon K, Taylor S, Pancino G, Barré-Sinoussi F, Scott-Algara D; Cambodian Early versus Late Introduction of Antiretroviral Drugs (CAMELIA) study team. Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. Blood. 2012;119(14):3315-3320. DOI: 10.1182/blood-2011-09-377523 27. Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, Todd M, Deribew A. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta-analysis. Journal of the International Association of Providers of AIDS Care. 2015;14(6):560-570. DOI: 10.1177/2325957415599210 28. Kanters S, Vitoria M, Zoratti M, Doherty M, Penazzato M, Rangaraj A, Ford N, Thorlund K, Anis PAH, Karim ME, Mofenson L, Zash R, Calmy A, Kredo T, Bansback N. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review and network meta-analysis. EClinicalMedicine. 2020;28:100573. DOI: 10.1016/j.eclinm.2020.100573 29. Dooley KE, Kaplan R, Mwelase N, Grinsztejn B, Ticona E, Lacerda M, Sued O, Belonosova E, Ait-Khaled M, Angelis K, Brown D, Singh R, Talarico CL, Tenorio AR, Keegan MR, Aboud M; International Study of Patients with HIV on Rifampicin ING study group. Dolutegravir-based antiretroviral therapy for patients coinfected with tuberculosis and human immunodeficiency virus: a multicenter, noncomparative, open-label, randomized trial. Clinical Infectious Diseases. 2020;70(4):549-556. DOI: 10.1093/cid/ciz256 30. Министерство здравоохранения РФ; Российское общество фтизиатров; Национальная ассоциация некоммерческих организаций фтизиатров «Ассоциация фтизиатров». Клинические рекомендации. Туберкулез у взрослых. Кодирование по Международной статистической классификации болезней и проблем, связанных со здоровьем: А15–А19. Год утверждения: 2022. Пересмотр не позднее: 2024. М., 2022. 151 с. [Ministry of Health of the Russian Federation; Russian Society of Phthisiologists; National Association of Non-profit Organizations of Phthisiologists "Association of Phthisiologists". Clinical recommendations. Tuberculosis in adults. ICD 10: A15–A19. Year of approval: 2022. Moscow, 2022. 151 p. (In Russ.).] 31. Tran HT, Van den Bergh R, Vu TN, Laukens K, Worodria W, Loembé MM, Colebunders R, Kestens L, De Baetselier P, Raes G; TB-IRIS Study Group. The role of monocytes in the development of tuberculosis-associated immune reconstitution inflammatory syndrome. Immunobiology. 2014;219(1):37-44. DOI: 10.1016/j.imbio.2013.07.004 32. European AIDS Clinical Society. EACS Guidelines, version 11.0, October 2021. Accessed 2023 Jan 10. https://api.hiv.plus/uploads/89db46739e4943029c8b88a38402c057.pdf    [ Содержание выпуска N 3/4 | Выпуски журнала | Список журналов ]